Back to PharmaIndex

LUMIGAN

BIMATOPROST

Drug details

API

BIMATOPROST

Drug classification

Dosage form

SOLUTION/DROPS;OPHTHALMIC

API strength per dosage

0.03% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Dose

Mechanism of action

Indications

Side effects

Pregnancy category

Precautions

Contraindications

PharmaProLearn

Excel Beyond Limits